Viral Oncology

 An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune system responses.

The potential of viruses as anti-cancer agents was first realised in the early twentieth century, although coordinated research efforts did not begin until the 1960s. A number of viruses including adenovirus, reovirus, measles, herpes simplex, Newcastle disease virus, and vaccinia have been clinically tested as oncolytic agents. Most current oncolytic viruses are engineered for tumour selectivity, although there are naturally occurring examples such as reovirus and the senecavirus, resulting in clinical trials

 

  • Oncovirus
  • HPV & Other Sexually Transmitted Diseases
  • Cancer Immunotherapy

Related Conference of Viral Oncology

November 18-19, 2019

World Congress on Histopathology

Berlin, Germany
December 02-03, 2019

International Conference on Virology & bacteriology

Manila, Philippines
January 16-17, 2020

International conference on Pediatric Pathology

Lisbon, Portugal
February 12-13, 2020

2nd International Conference on Molecular Pathology

Paris | France
April 13-14, 2020 |

11thInternational Conference on Chemistry

Zagreb, Croatia
April 29-30, 2020

18th European Pathology Congress

Prague, Czech Republic

International Conference on Surgical Pathology

Holiday Inn Amsterdam - Arena Towers,Amsterdam,Netherlands
September 07-08, 2020 -

2nd World Neonatology and Child Care Meeting

Prague, Czech Republic

Viral Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in